Yield10 Bioscience
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Yield10 Bioscience's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 87% to $60,000. Profit margin reached -24092%. Total operating expenses were $14,477,000.

Profit Margin

Yield10 Bioscience, Inc. (NASDAQ:YTEN): Profit margin
2014 2.8M -29.53M -1054.79%
2015 2.59M -23.68M -912.91%
2016 1.15M -7.60M -656.08%
2017 944K -9.39M -995.34%
2018 556K -9.18M -1651.98%
2019 806K -12.95M -1607.44%
2020 799K -10.20M -1277.35%
2021 614K -11.03M -1796.58%
2022 450K -13.56M -3014.67%
2023 60K -14.45M -24091.67%

YTEN Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
60K450K614K799K806K556K944K1.15M2.59M2.8M
Cost of revenue
290K656K578K5.22M4.84M4.78M4.59M5.67M660K1.48M
Gross profit
-230K-206K36K-4.42M-4.04M-4.22M-3.65M-4.51M1.93M1.31M
Operating exp.
Research and development
8.32M7.75M6.20M5.36M4.84M4.78M4.59M5.67M16.57M17.34M
Selling and marketing
0000000000
Total operating expenses
14.47M13.90M12.30M10.40M9.40M9.87M10.22M11.40M25.67M28.14M
Operating income
-14.41M-13.45M-11.69M-9.60M-8.59M-9.31M-9.28M-10.24M-23.74M-26.82M
Other income (expenses), net
-38K41K697K-541K-4.61M134K-113K-38K29K61K
Income before tax
-14.45M-13.41M-10.99M-10.15M-13.21M-9.18M-9.39M-10.28M-23.68M-26.76M
Income tax expense
0156K36K56K-254K104K113K-1.09M-62K2.70M
Net income
-14.45M-13.56M-11.03M-10.20M-12.95M-9.18M-9.39M-7.60M-23.68M-29.53M
Earnings per share
Basic EPS
-43.66-66.25-55.95-103.21-851.98-887.78-2.77K-2.65K-9.18K-27.96K
Diluted EPS
-43.66-66.25-55.95-103.21-851.98-887.78-2.77K-2.65K-9.18K-27.96K
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source